Emtricitabine and blood potassium decreased 
Emtricitabine and blood potassium decreased Patient Reports February 11, 2012
Emtricitabine Side Effects Report #4941177-9
Emtricitabine side effect was reported by a Consumer or non-health professional from GERMANY on Feb 21, 2006. Male patient, 38 years of age, weighting 100.5 lb, was diagnosed with hiv infection
and was treated with Emtricitabine. After drug was administered, patient experienced the following side effects: blood calcium decreased, blood chloride increased, blood potassium decreased, blood sodium increased, blood urea increased, blood uric acid decreased, coma hepatic, haemoglobin decreased, kaposi's sarcoma . Emtricitabine dosage: unknown. During the same period patient was treated with SUSTIVA, DIFLUCAN, PENTACARINAT, NEUPOGEN, MYCOBUTIN, ALLOPURINOL, KLACID, CYCLOPHOSPHAMIDE DOXORUBICIN. Patient died on 02/05/2006.Emtricitabine Side Effects Report #5451579-2
Emtricitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 04, 2007. Female patient, 34 years of age, weighting 94.80 lb, was diagnosed with hiv infection
and was treated with Emtricitabine. After drug was administered, patient experienced the following side effects: abasia, abdominal pain , anaemia, anorexia, blood albumin decreased, blood potassium decreased, bronchitis , cachexia, confusional state. Emtricitabine dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, KALETRA, LOPERAMIDE, MICONAZOLE ORAL GEL, CIPROFOXAN. Patient was hospitalized. Patient died on 07/30/2007.Emtricitabine Side Effects Report #5590738-5
Emtricitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 07, 2008. Female patient, 34 years of age, weighting 104.9 lb, was diagnosed with hiv infection
and was treated with Emtricitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood potassium decreased, cough, dehydration, gastroenteritis , hypotension, hypothermia . Emtricitabine dosage: unknown. During the same period patient was treated with ALUVIA. Patient was hospitalized. Patient died on 11/21/2007.Emtricitabine Side Effects Report #5630093-5
Emtricitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 06, 2008. Female patient, 34 years of age, weighting 104.9 lb, was diagnosed with hiv infection
and was treated with Emtricitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood potassium decreased, blood sodium increased, cough, dehydration, disease progression, gastroenteritis cryptosporidial. Emtricitabine dosage: unknown. During the same period patient was treated with ALUVIA, FLUCONAZOLE. Patient was hospitalized. Patient died on 11/21/2007.Emtricitabine Side Effects Report #5320735-6
Emtricitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on May 01, 2007. Male patient, 32 years of age, weighting 115.1 lb, was diagnosed with hiv infection
, prophylaxis and was treated with Emtricitabine. After drug was administered, patient experienced the following side effects: abdominal pain upper, band neutrophil percentage increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood phosphorus increased, blood potassium decreased, cough. Emtricitabine dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, EFAVIRENZ, VITAMIN CAP, ASCORBIC ACID, SULFAMETHOXAZOLE AND TRIMETHOPRIM. Patient was hospitalized. Patient recovered.Emtricitabine Side Effects Report #5574736-3
Emtricitabine side effect was reported by a Health Professional from UNITED STATES on Dec 21, 2007. Female patient, 28 years of age, weighting 121.3 lb, was diagnosed with hiv infection
and was treated with Emtricitabine. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood potassium decreased, haematocrit decreased, haemoglobin decreased, malaria , postpartum haemorrhage, pyrexia. Emtricitabine dosage: 200 MG QD PO. During the same period patient was treated with DIDANOSINE, ATAZANAVIR SULPHATE, TRUVADA, ZIDOVUDINE, NEVIRAPINE, FERROUS SULPHATE. Patient was hospitalized. Patient recovered.